JPS4875564A - - Google Patents
Info
- Publication number
- JPS4875564A JPS4875564A JP487572A JP487572A JPS4875564A JP S4875564 A JPS4875564 A JP S4875564A JP 487572 A JP487572 A JP 487572A JP 487572 A JP487572 A JP 487572A JP S4875564 A JPS4875564 A JP S4875564A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Furan Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP487572A JPS4875564A (es) | 1972-01-08 | 1972-01-08 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP487572A JPS4875564A (es) | 1972-01-08 | 1972-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS4875564A true JPS4875564A (es) | 1973-10-11 |
Family
ID=11595831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP487572A Pending JPS4875564A (es) | 1972-01-08 | 1972-01-08 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS4875564A (es) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667330B2 (en) | 2002-01-31 | 2003-12-23 | Galileo Pharmaceuticals, Inc. | Furanone derivatives |
| US9278085B2 (en) | 2006-02-22 | 2016-03-08 | Edison Pharmaceuticals, Inc. | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| US9370496B2 (en) | 2009-04-28 | 2016-06-21 | Edison Pharmaceuticals, Inc. | Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones |
| US10105325B2 (en) | 2008-09-10 | 2018-10-23 | Bioelectron Technology Corporation | Treatment of pervasive developmental disorders with redox-active therapeutics |
| US10703701B2 (en) | 2015-12-17 | 2020-07-07 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
| US11021424B2 (en) | 2005-06-01 | 2021-06-01 | Ptc Therapeutics, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
-
1972
- 1972-01-08 JP JP487572A patent/JPS4875564A/ja active Pending
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667330B2 (en) | 2002-01-31 | 2003-12-23 | Galileo Pharmaceuticals, Inc. | Furanone derivatives |
| EP1478634A1 (en) * | 2002-01-31 | 2004-11-24 | Galileo Pharmaceuticals, Inc. | Furanone derivatives |
| EP1478634A4 (en) * | 2002-01-31 | 2006-02-01 | Galileo Pharmaceuticals Inc | FURANONE DERIVATIVES |
| US11021424B2 (en) | 2005-06-01 | 2021-06-01 | Ptc Therapeutics, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| US9278085B2 (en) | 2006-02-22 | 2016-03-08 | Edison Pharmaceuticals, Inc. | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| US9932286B2 (en) | 2006-02-22 | 2018-04-03 | Bioelectron Technology Corporation | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| US10105325B2 (en) | 2008-09-10 | 2018-10-23 | Bioelectron Technology Corporation | Treatment of pervasive developmental disorders with redox-active therapeutics |
| US10736857B2 (en) | 2008-09-10 | 2020-08-11 | Ptc Therapeutics, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
| US10195161B2 (en) | 2009-04-28 | 2019-02-05 | Bioelectron Technology Corporation | Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones |
| US9370496B2 (en) | 2009-04-28 | 2016-06-21 | Edison Pharmaceuticals, Inc. | Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones |
| US10703701B2 (en) | 2015-12-17 | 2020-07-07 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
| US10981855B2 (en) | 2015-12-17 | 2021-04-20 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
| US11680034B2 (en) | 2015-12-17 | 2023-06-20 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |